Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Pulse Biosciences, Inc. logo

Pulse Biosciences, Inc. (PLSE) Stock Ticker

NASDAQ: PLSE · Healthcare · Medical - Instruments & Supplies
$53.26-0.39%
USD · as of 2026-09-28 · market cap $3.6B
Open PLSE in TickrDownload for iPhone

PLSE right now

25% of the float is sold short.
Options expect by Oct 6±10.1%
Options expect by Oct 29±20.9%
Priced in for Nov 4 earnings±22.9%
IV rank (30-day)14% · cheap
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full PLSE picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on PLSE
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Pulse Biosciences, Inc.

Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.

PLSE stock facts

Ticker symbolPLSE
ExchangeNASDAQ Capital Market
SectorHealthcare
IndustryMedical - Instruments & Supplies
Market cap$3.6B
CEOPaul Arthur LaViolette
Employees116
HeadquartersMiami, FL, US
IPO date2016-05-18
Websitewww.pulsebiosciences.com

What you can see for PLSE on Tickr

Live PLSE price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the PLSE report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Pulse Biosciences, Inc.?

The ticker symbol for Pulse Biosciences, Inc. is PLSE, listed on the NASDAQ Capital Market.

What is PLSE?

Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively…

HomeExploreMarketLists
All pages